SLC3A2 and colorectal carcinoma: Furthermore, experiments using patient-derived normal and tumoral CRC organoids, as well as studies using xenografted cell lines in mice and PDXs show that the anti-CD98hc ADC exerts ex vivo and in vivo antitumoral activity.